Abstract: Hepatitis G virus (HGV) infection is a worldwide health problem causing acute and chronic non A-E hepatitis. Because HGV and hepatitis C virus (HCV) share same modes of transmission, co-infection with the two viruses is not uncommon especially among people at high risk of parenteral infection. The aim of this study was to determine the prevalence of HGV among HCV virus cases, and to determine the degree of concurrent association between HGV and other prevalent infections in Egypt as Schistosoma, and hepatitis B virus (HBV) infections. This study included 100 blood donors attending Alexandria University Blood Bank in EL Shatby, proved to be positive for HCV antibodies by enzyme linked immunosorbant assay (ELISA) technique.
INTRODUCTION
Viral hepatitis is a major global public health problem. It is the most common cause of chronic hepatitis resulting in liver fibrosis, cirrhosis, and liver carcinoma. infection only. (14, 15) In this study we aimed to determine the prevalence of HGV among HCV cases, and to determine the degree of concurrent association between HGV and other prevalent infections in Egypt as Schistosoma, and HBV infections. HGV RNA was detected using nested PCR technique. (16) RNA was extracted from 100 μl of serum samples by using Promega SV total RNA isolation system and resuspended in 100 μl of elution buffer.
SUBJECTS AND METHODS
The extracted RNA was subjected to reverse transcription and DNA amplification, both were done together using the Promega Access Quick RT-PCR System. For first round of amplification outer primers were used:
reverse), 5`-CCTATTGGTCAAGAGAGACAT-3`; The amplification protocol included 25
cycles of denaturation at 94˚C for 45 seconds, annealing at 55˚C for 45 seconds and extension at 72˚C for 90 seconds.
Reamplifications of the resulted amplicons were done using specific inner primers. G134
The second amplification was done using promega Go Taq (25) found that co-infection between HGV and HCV was proved in 22% of patients. Alknawy et al, (2002) (26) reported co-infection between the two viruses in 31% of Saudi patients. In the United Arab Emirates, the percentage was 47.6 % as reported by Abou Odeh et al, (2005) . (27) In 2008, Rajan et al, (20) found that co-infection of HGV and HCV in chronic liver disease cases was 71.4%. While Salehi et al, (2009) (28) stated that the prevalence of HGV and HCV coinfection was 25%.
On the other hand, many studies reported a lower frequency of HGV coinfection among chronic HCV patients ranging from 5%-14%. (16, (29) (30) (31) (32) (33) The low (35) reported that repeated blood transfusions more than five times increases the risk of HGV infection significantly. Abad et al, (36) found that the prevalence of HGV RNA in multi-transfused thalassemic patients was 2.24%. In 2008, Samadi et al (37) reported that the number of transfusion of blood and blood products increased the risk of HGV infection.
In this study Schistosoma antibodies (38) reported that the presence of GBV-C RNA was associated significantly with a history of schistosomiasis. Another work by Gallian et al, (1998) (39) (2005) . (27) Nevertheless, Rajan et al, (2008) (20) documented that the prevalence of HGV RNA in chronic liver disease cases co-infected with HBV was 50%.
From this study it could be concluded that 
